Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21CIP1 levels in androgen-independent human prostate cancer cells

Selena KNIGHT-KRAJEWSKI; Catherine F WELSH; YUNQI YUNQI LIU; Leah S LYONS; Joanne M FAYSAL; Eddy S YANG; Kerry L BURNSTEIN

doi:10.1038/sj.onc.1207708

Back

Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21CIP1 levels in androgen-independent human prostate cancer cells

Journal article

Peer reviewed

Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21CIP1 levels in androgen-independent human prostate cancer cells

Selena KNIGHT-KRAJEWSKI, Catherine F WELSH, YUNQI YUNQI LIU, Leah S LYONS, Joanne M FAYSAL, Eddy S YANG and Kerry L BURNSTEIN

Oncogene, Vol.23(32), pp.5513-5522

2004

DOI: https://doi.org/10.1038/sj.onc.1207708

Abstract

Fundamental and applied biological sciences. Psychology

Tumors of the urinary system

Urinary tract. Prostate gland

Gynecology. Andrology. Obstetrics

Nephrology. Urinary tract diseases

Biological and medical sciences

Cell physiology

Molecular and cellular biology

Medical sciences

Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes

Male genital diseases

Tumors

Metrics

17 Record Views

37 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.96 Cell Biology; 1.96.224 Integrins
Web Of Science research areas: Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity; Oncology
ESI research areas: Molecular Biology & Genetics

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21CIP1 levels in androgen-independent human prostate cancer cells
Creators: Selena KNIGHT-KRAJEWSKI - Department of Molecular and Cellular Pharmacology, University of Miami School of Medicine, 1600 NW 10th Ave., Miami, FL 33136, United States
Catherine F WELSH - Department of Medicine, University of Miami School of Medicine, 1600 NW 10th Ave., Miami, FL 33136, United States
YUNQI YUNQI LIU - Department of Medicine, University of Miami School of Medicine, 1600 NW 10th Ave., Miami, FL 33136, United States
Leah S LYONS - Department of Molecular and Cellular Pharmacology, University of Miami School of Medicine, 1600 NW 10th Ave., Miami, FL 33136, United States
Joanne M FAYSAL - Department of Molecular and Cellular Pharmacology, University of Miami School of Medicine, 1600 NW 10th Ave., Miami, FL 33136, United States
Eddy S YANG - Department of Molecular and Cellular Pharmacology, University of Miami School of Medicine, 1600 NW 10th Ave., Miami, FL 33136, United States
Kerry L BURNSTEIN - Department of Molecular and Cellular Pharmacology, University of Miami School of Medicine, 1600 NW 10th Ave., Miami, FL 33136, United States
Publication Details: Oncogene, Vol.23(32), pp.5513-5522
Publisher: Nature Publishing; Basingstoke
Academic Unit: Miller School of Medicine; Molecular and Cellular Pharmacology Research; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031561168302976